Recombinant Factor VIIa for Reversal of Warfarin Anticoagulation in Intracranial Hemorrhage

Surgery for Cerebral Stroke
doi 10.2335/scs.40.14
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Society on Surgery for Cerebral Stroke

Related search

Comparison of 3-Factor Prothrombin Complex Concentrate and Low-Dose Recombinant Factor VIIa for Warfarin Reversal

World Journal of Emergency Surgery
SurgeryEmergency Medicine
2014English

Recombinant Factor VIIa Plus Surgery for Intracerebral Hemorrhage

Canadian Journal of Neurological Sciences
MedicineNeurology
2008English

Cost Effectiveness of Recombinant Factor VIIa for Treatment of Intracerebral Hemorrhage

BMC Neurology
MedicineNeurology
2008English

Use of Recombinant Factor VIIa in Symptomatic Intracerebral Hemorrhage Following Intravenous Thrombolysis

Clinics and Practice
2015English

Tissue Factor in Brain Is Not Saturated With Factor VIIa: Implications for Factor VIIa Dosing in Intracerebral Hemorrhage

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2009English

Reversal of Oral Anticoagulation in Patients With Acute Intracerebral Hemorrhage

Critical Care
Critical CareIntensive Care Medicine
2019English

Can Tromboelastography Guide Recombinant Factor VIIA Therapy for Refractory Hemorrhage After Cardiac Surgery? An Observational Study

Canadian Journal of Anaesthesia
MedicineAnesthesiologyPain Medicine
2008English

Life-Threatening Pulmonary Hemorrhage Responds to Recombinant Factor VIIa: A Case Series in South Florida Hospitals

Cureus
2019English

Use of Recombinant Factor VIIa for Control of Combat-Related Hemorrhage: Findings From the U.S. Navy-Marine Corps Combat Trauma Registry

2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy